BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND EXT1, ttv, 2131, ENSG00000182197, EXT, Q16394 AND Prognosis
6 results:

  • 1. Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma.
    Tan D; Miao D; Zhao C; Shi J; Lv Q; Xiong Z; Yang H; Zhang X
    BMC Cancer; 2023 Mar; 23(1):264. PubMed ID: 36949462
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Mutant CDKN2A regulates P16/p14 expression by alternative splicing in renal cell carcinoma metastasis.
    Sun Q; Chen S; Hou Y; Wen X; Teng X; Zhang H; Lai C; Lai M
    Pathol Res Pract; 2021 Jul; 223():153453. PubMed ID: 34022680
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Quantification of contrast-uptake as imaging biomarker for disease progression of renal cell carcinoma after tumor ablation.
    Tegel BR; Huber S; Savic LJ; Lin M; Gebauer B; Pollak J; Chapiro J
    Acta Radiol; 2020 Dec; 61(12):1708-1716. PubMed ID: 32216452
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The role of lymph node dissection in the management of renal cell carcinoma: a systematic review and meta-analysis.
    Bhindi B; Wallis CJD; Boorjian SA; Thompson RH; Farrell A; Kim SP; Karam JA; Capitanio U; Golijanin D; Leibovich BC; Gershman B
    BJU Int; 2018 May; 121(5):684-698. PubMed ID: 29319926
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases.
    Kalra S; Atkinson BJ; Matrana MR; Matin SF; Wood CG; Karam JA; Tamboli P; Sircar K; Rao P; Corn PG; Tannir NM; Jonasch E
    BJU Int; 2016 May; 117(5):761-5. PubMed ID: 26032863
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Squamous cell carcinoma (SCC)--nature and usage in patients with cervical carcinoma].
    Bocheva Y; Bochev P; Chaushev B; Ivanov S
    Akush Ginekol (Sofiia); 2015; 54(2):29-34. PubMed ID: 25909138
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.